Skip to main content

J1932 HCPCS Level II Code: Injection, lanreotide, (cipla), 1 mg

Medicare Coverage & Payment

  • CMS short descriptor: Inj, lanreotide, (cipla) 1mg
  • Medicare coverage: Carrier judgment (CMS coverage code C)
  • Payment category: Drugs (pricing indicator 51)
  • BETOS: O1E — Other drugs
  • Last CMS action effective: October 1, 2022

Source: CMS HCPCS Level II release. Coverage codes indicate how Medicare treats the code, not whether a specific claim will be paid; payer policy and documentation still govern.

Change history

  • October 1, 2022
    Added to the code set
    Injection, lanreotide, (cipla), 1 mg

Drug products (NDC)

CMS ASP NDC-HCPCS Crosswalk · 2026 Q3

Medicare Part B payment limit (ASP + 6%): $20.33

69097-0870-67 — Lanreotide — Cipla USA, Inc. (size 0.5 × qty 1 (1 MG per billing unit))

Related Codes

Same drug, other billing codes

CMS's ASP crosswalk lists these HCPCS codes for the same drug.

J1930 — Injection, lanreotide, 1 mg

From the CMS ASP NDC-HCPCS Crosswalk and Part B Payment Limit File. Payment limits apply per HCPCS billing code, not per package.

Contextual Map

Every relationship of J1932 in one view: hierarchy, official tabular instructions in both directions, clinical classification, risk adjustment, MS-DRG participation, index terms and change history — each edge carrying the CMS source it derives from.

Nearest codes (23)

Change history

  • October 1, 2022 — Added to the code set [Change history]

Nearest Codes in This Family

Official HCPCS Level II classifications closest to J1932 in its code family, with their registry titles.